Kovina Therapeutics operates as a pre-clinical biotechnology company.
Kovina Therapeutics operates as a pre-clinical biotechnology company aims to discover a non-surgical, medical treatment for Human Papillomavirus (HPV) infections and cancers.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 1, 2022 | Grant | $275K | 1 | National Institute of Dental and Craniofacial Research (NIDCR) | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institute of Dental and Craniofacial Research (NIDCR) | Yes | Grant |